Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.51 USD
+0.02 (0.63%)
Updated Apr 26, 2024 03:36 PM ET
After-Market: $2.49 -0.02 (-0.62%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Balance Sheet
Fiscal Year End for Cellectis SA falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 98 | 186 | 268 | 361 |
Receivables | NA | 15 | 30 | 16 | 12 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 2 | 3 |
Other Current Assets | NA | 31 | 10 | 30 | 16 |
Total Current Assets | NA | 144 | 225 | 315 | 392 |
Net Property & Equipment | NA | 64 | 79 | 72 | 24 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 2 | 2 | 1 |
Deposits & Other Assets | NA | 9 | 7 | 7 | 6 |
Total Assets | NA | 261 | 382 | 469 | 467 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 21 | 24 | 25 | 29 |
Current Portion Long-Term Debt | NA | 5 | 2 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 29 | 15 | 21 | 32 |
Total Current Liabilities | NA | 63 | 49 | 52 | 63 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 21 | 20 | 29 | 47 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 2 | 5 | 4 | 3 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 135 | 146 | 161 | 112 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3 | 3 | 3 | 3 |
Capital Surplus | NA | 583 | 935 | 864 | 843 |
Retained Earnings | NA | -440 | -698 | -587 | -508 |
Other Equity | NA | -21 | -3 | 29 | 18 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 126 | 236 | 309 | 355 |
Total Liabilities & Shareholder's Equity | NA | 261 | 382 | 469 | 467 |
Total Common Equity | 0 | 126 | 236 | 309 | 355 |
Shares Outstanding | 55.50 | 45.60 | 45.40 | 42.40 | 42.40 |
Book Value Per Share | 0.00 | 2.76 | 5.21 | 7.28 | 8.38 |
Fiscal Year End for Cellectis SA falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 67 | 86 | 88 |
Receivables | NA | NA | 21 | 20 | 19 |
Notes Receivable | NA | NA | 0 | 0 | 0 |
Inventories | NA | NA | 0 | 0 | 0 |
Other Current Assets | NA | NA | 8 | 8 | 30 |
Total Current Assets | NA | NA | 96 | 113 | 137 |
Net Property & Equipment | NA | NA | 57 | 59 | 62 |
Investments & Advances | NA | NA | 0 | 0 | 0 |
Other Non-Current Assets | NA | NA | 0 | 0 | 0 |
Deferred Charges | NA | NA | 0 | 0 | 0 |
Intangibles | NA | NA | 1 | 1 | 1 |
Deposits & Other Assets | NA | NA | 17 | 13 | 8 |
Total Assets | NA | NA | 210 | 228 | 251 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | 0 | 0 |
Accounts Payable | NA | NA | 20 | 19 | 22 |
Current Portion Long-Term Debt | NA | NA | 5 | 5 | 5 |
Current Portion Capital Leases | NA | NA | 0 | 0 | 0 |
Accrued Expenses | NA | NA | 0 | 0 | 0 |
Income Taxes Payable | NA | NA | 0 | 0 | 0 |
Other Current Liabilities | NA | NA | 10 | 9 | 25 |
Total Current Liabilities | NA | NA | 44 | 42 | 60 |
Mortgages | NA | NA | 0 | 0 | 0 |
Deferred Taxes/Income | NA | NA | 0 | 0 | 0 |
Convertible Debt | NA | NA | 0 | 0 | 0 |
Long-Term Debt | NA | NA | 43 | 46 | 20 |
Non-Current Capital Leases | NA | NA | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 3 | 43 | 3 | |
Minority Interest (Liabilities) | NA | NA | 0 | 0 | 0 |
Total Liabilities | NA | NA | 134 | 131 | 131 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | 0 | 0 |
Common Stock (Par) | NA | NA | 3 | 3 | 3 |
Capital Surplus | NA | NA | 473 | 476 | 608 |
Retained Earnings | NA | NA | -363 | -346 | -469 |
Other Equity | NA | NA | -38 | -37 | -22 |
Treasury Stock | NA | NA | 0 | 0 | 0 |
Total Shareholder's Equity | NA | NA | 76 | 97 | 120 |
Total Liabilities & Shareholder's Equity | NA | NA | 210 | 228 | 251 |
Total Common Equity | 0 | 0 | 76 | 97 | 120 |
Shares Outstanding | 55.50 | 55.50 | 55.50 | 55.50 | 55.50 |
Book Value Per Share | 0.00 | 0.00 | 1.37 | 1.74 | 2.17 |